insights_auto
Why is KNSA up 6.25%?
Dive Deeperchevron_right
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
$93.86
arrow_upward
+6.25%(+5.52) 1D
$95.00
arrow_upward
+1.21% (+1.14)bedtimeAfter hours
Closed: Nov 6, 4:00:01āÆPM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
$88.92
High
$94.48
Low
$88.41
Mkt. cap
7.37B
Avg. vol.
830.89K
Volume
636.35K
P/E ratio
71.64
52-wk high
$98.48
52-wk low
$37.02
EPS
$1.31
Beta
0.07
Shares outstanding
48.84M
No. of employees
366
Open
$88.92
High
$94.48
Low
$88.41
Mkt. cap
7.37B
Avg. vol.
830.89K
Volume
636.35K
P/E ratio
71.64
52-wk high
$98.48
52-wk low
$37.02
EPS
$1.31
Beta
0.07
Shares outstanding
48.84M
No. of employees
366
News stories
From web sources and news partners
TradingView
·
1 day ago
H&S in a Falling Channel, Short Toward 7,000 for CAPITALCOM:SPX500 by Audacity618
BigGo Finance
·
2 hours ago
Global AI and Semiconductor Stocks Plunge; S&P 500 Tumbles 4.4% in a Single Day as Markets Watch Whether Three Central Banks Will Raise Rates in December
Quantisnow
·
9 hours ago
Consumer Staples sector performance - S&P 500 consumer staples stocks
www.tmgm.com
·
1 day ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersLondon, England, United Kingdom
SectorHealth Care
IndustryBiotechnology
Websitekiniksa.com